Dr. Kathy Yu leads business development activities at ImmuneOnco. She has 25 years of experience in biopharmaceutical industry. Before joining ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd., she worked at Novartis, Smith, Kline & French Laboratories, UCB, Pfizer, Merck Serono and Alphamab Oncology, where she held various positions in medical and clinical operation, marketing, business development and strategic planning.
In the recent 15 years, Dr. Yu has been focusing more on business development and strategic planning. She served as Head of Business Development at UCB, Pfizer and Merck Serono China, where she led important licensing, co-development and co-commercialization projects. She also has experience in managing Joint Venture collaboration and post-acquisition integration.
Dr. Kathy Yu holds a doctoral degree in Clinical Medicine from Peking Union Medical College and a Master degree in Business Administration from Rutgers University.